Mercer Global Advisors
QTTB icon

Mercer Global Advisors’s Q32 Bio QTTB Stock Holding History

Mercer Global Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25 Buy
+2
New +$17 ﹤0.01% 6037

Other funds holding QTTB

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mercer Global Advisors's QTTB Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Q32 Bio (QTTB) in Q2 2026: 2 shares worth $25. The stake represents ﹤0.01% of the portfolio and ranks #6037 among its holdings.

23 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Mercer Global Advisors held 2 shares of Q32 Bio worth $25 as of Q2 2026.
  • Q32 Bio was a new Mercer Global Advisors position in Q2 2026.
  • Q32 Bio made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #6037 holding.
  • 23 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.